T. Rowe Price Associates’s Oak Street Health, Inc. OSH Stock Holding History

T. Rowe Price Associates’s Portfolio OSH Stock Details OSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-59,586	Closed	-$2.31M	–	3030
2023 Q1	$2.31M	Sell	59,586 -663,381	-92%	-$21.4M	﹤0.01%	1419
2022 Q4	$15.6M	Sell	722,967 -39,891	-5%	-$834K	﹤0.01%	975
2022 Q3	$18.7M	Buy	762,858 +208,614	+38%	+$5.52M	﹤0.01%	925
2022 Q2	$9.11M	Sell	554,244 -37,731	-6%	-$733K	﹤0.01%	1336
2022 Q1	$15.9M	Buy	591,975 +28,213	+5%	+$595K	﹤0.01%	1290
2021 Q4	$18.7M	Sell	563,762 -1,171,601	-68%	-$44.3M	﹤0.01%	1301
2021 Q3	$73.8M	Buy	1,735,363 +11,108	+0.6%	+$597K	0.01%	879
2021 Q2	$101M	Buy	1,724,255 +87,685	+5%	+$5.22M	0.01%	776
2021 Q1	$88.8M	Buy	1,636,570 +165,236	+11%	+$9.19M	0.01%	813
2020 Q4	$87.1M	Buy	1,471,334 +61,852	+4%	+$3.24M	0.01%	775
2020 Q3	$72.8M	Buy	+1,409,482	New	+$63.1M	0.01%	753

Other funds holding OSH

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

T. Rowe Price Associates's OSH Position: Q2 2023 in Review

T. Rowe Price Associates sold out of Oak Street Health, Inc. (OSH) in Q2 2023, closing a stake of 59,586 shares — an estimated $2.31M sold.

T. Rowe Price Associates first reported a position in OSH in Q3 2020 and held it in 11 quarters. The position peaked at $101M in Q2 2021. 2 funds tracked by Wall St. Rank hold OSH as of Q2 2023.

T. Rowe Price Associates reported no remaining Oak Street Health, Inc. position as of Q2 2023 after selling out during the quarter.
T. Rowe Price Associates sold 59,586 Oak Street Health, Inc. shares in Q2 2023, an estimated $2.31M.
T. Rowe Price Associates first reported a position in Oak Street Health, Inc. in Q3 2020 and held it in 11 quarters.
T. Rowe Price Associates's Oak Street Health, Inc. position peaked at $101M in Q2 2021.
2 funds tracked by Wall St. Rank held Oak Street Health, Inc. as of Q2 2023.

Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.